| Literature DB >> 31785178 |
Elisa Millana Fañanás1, Sofia Todesca1, Alessandro Sicorello2,3, Laura Masino4, Petr Pompach5,6, Francesca Magnani1, Annalisa Pastore2,3, Andrea Mattevi1.
Abstract
It is now accepted that reactive oxygen species (Entities:
Keywords: EF-hands; NMR; calcium activation; enzyme; structure
Mesh:
Substances:
Year: 2019 PMID: 31785178 PMCID: PMC7317449 DOI: 10.1111/febs.15160
Source DB: PubMed Journal: FEBS J ISSN: 1742-464X Impact factor: 5.542
Figure 1The EF‐domain of hNOX5 undergoes a large structural transition upon calcium binding. (A) NOX5 comprises three domains: The EF‐domain with four EF‐hand motifs (EF), the transmembrane domain, and the DH domain. (B) Size‐exclusion chromatography (Superdex‐75 10/300 column; GE Healthcare) elution profiles in presence or absence of calcium present different behavior, suggesting a more globular shape in the holo state. (C, D) CD spectra, and 1H‐15N HSQC spectra of the apo (calcium‐free) and holo (calcium‐bound) forms of the EF‐domain of hNOX5. The apo protein contained 200 µm EGTA, while the holo state was measured in the presence of 250 µm CaCl2, at 27 °C. Far‐UV‐CD measurements were done in duplicate. The CD spectra showed a lower secondary content in the apo state, consistently with the NMR, where there is a clear lack of proton dispersity (left) with respect to the defined resonances of the holo state (right). (E) Quality of the 1H‐15N HSQC NMR spectrum of the human holo EF‐domain is poor at low temperatures (10 °C) and improves at 27 and 35 °C.
Intensity of the CD band at 222 nm for the apo and holo states of the EF‐domain of hNOX5. The measurements were done in duplicates
| Δεmwr at 222 nm (M−1·cm−1) | |||
|---|---|---|---|
| Apo | Holo | Increase (%) | |
| Full‐length | −3.44 | −4.28 | 14.7 |
| N‐terminal lobe | −2.71 | −4.00 | 12.2 |
| C‐terminal lobe | −4.5 | −4.42 | 17.7 |
Figure 2The regulatory domain of NOX5 contains four active calcium‐specific EF‐hands. (A) In the holo state, the 1H 15N HSQC spectra display three resonances at the proton frequencies 11.2, 10.86, and 10.705 p.p.m. likely corresponding to Gly57, Gly93, and Gly137. (B) Comparison of HDX performed with the purified hEF domain for the apo‐ and the holo‐form, independently. The overlap of both results shows four regions where the presence of calcium induced a reduction of the deuteration level, after 20 seconds of reaction. These four regions correspond to the predicted four EF‐hand motifs. (C) Sequences of the four EF‐hands motifs of hNOX5. EF‐hands 2, 3, and 4 have a glycine in position 6, while EF‐hand 1 contains glutamate. (D) Overlap of the 1H‐15N HSQC spectra measured with or without magnesium demonstrates that magnesium does not induce the transition to the holo conformation, contrary to calcium (Fig. 1C).
Figure 3SEC‐MALLS analysis shows that the EF‐domain of hNOX5 is mostly monomeric in solution, with a 15–20% dimerization. Samples (100 μL) were applied to a Superdex 200 10/300 GL column mounted on a Jasco HPLC equilibrated in 50 mM Hepes buffer at pH 7.0, 25 mM NaCl, 0.5 TCEP, at a flow rate of 1 mL·min−1. Measurements were recorded using a DAWN HELEOS laser photometer and an OPTILAB‐rEX differential refractometer (ΔRI) (dn/dc = 0.186).
Figure 4CD and NMR characterization of the N‐ and C‐lobes of hNOX5 EF‐domain. (A, B) CD spectra of the two proteins. The apo proteins (blue discontinuous line) contained 200 µm EGTA, while the holo proteins (orange continuous line) were incubated in a solution containing 250 µm CaCl2. Differences between apo and holo are mainly visible for the C‐lobe. Far‐UV‐CD measurements were done in duplicate. (C, D) The 1H‐15N HSQC spectrum of the N‐lobe apo state has a good dispersity in contrast to the poor dispersity of the apo C‐lobe protein. (E, F) Both N‐ and C‐lobes display an excellent dispersion in the holo state, leading to conclude that both are highly structured in presence of calcium. All proteins were in 50 mM Hepes buffer at pH 7.0, 25 mM NaCl, 0.5 TCEP. The measurements were carried out at 27 °C.
Figure 5Lack of additivity of the two halves of the EF‐domain. The spectrum of the full‐length EF‐domain (gray) does not match the spectrum calculated by the addition of the 1H‐15N HSQC spectra at 800 MHz of the N‐ (green) and C‐ (purple) lobes. All proteins were in 50 mM Hepes buffer at pH 7.0, 25 mM NaCl, 0.5 TCEP. The measurements were carried out at 27 °C.
Figure 6Alignment of human and C. stagnale NOX5 sequences prepared using ESPript3. UNIPROT sequences codes: csNOX5 K9WT99-1; hNOX5 Q96PH1-4.
Figure 7The C‐lobe of the EF‐domain is the main element for the binding to the DH‐domain. (A, B) In the absence of calcium, none of the lobes of the human EF‐domain present clear spectral differences when a twofold excess of the C. stagnale DH‐domain was present. (C, D) In the presence of calcium, the spectrum of the N‐lobe remains unperturbed by the DH‐domain, while the C‐lobe is highly affected. The intensities of several resonances are decreased or lost as the result of a weak yet clear interaction.
Figure 8Identification of the residues involved in the interaction between the C‐lobe of the human EF‐domain and the DH‐domain of csNOX5. (A, B) NMR spectra and residue assignment of the C‐lobe in absence and presence of the DH‐domain. (C) The interacting residues (red) are mainly located in the loops of EF‐hands 3 and 4 (underlined in the sequence). The terminal alanines (in brackets) are an addition due to cloning needs.
Figure 9Mutagenesis targeting the EF‐domain binding area. (A) Western blot analysis of the semi‐purified membranes of the csNOX5 mutants indicated that all variants had expression levels similar to the wild‐type, except for the N‐lobe truncation that had a lower expression. Because the extract is not pure protein, these methods give only a comparative impression of the relative expression. The marker used was Precision Plus Protein™ Dual Color Standards (Bio‐Rad). Molecular weights are in kDa. The high‐molecular weight species are most‐likely protein aggregates. The Western blot was repeated in triplicates. (B) The csNOX5 wild‐type activity in response to increasing concentrations of calcium was measured in membrane fractions following the reduction of cytochrome c (Sigma). At 1 mM CaCl2 plateau was reached. Activity measurements were carried out in triplicate. (C) Sequence comparison of the regulatory ‘region EF‐binding domain’ on the DH domain of csNOX5 and hNOX5 with the corresponding protein regions of hNOX1‐4 and human DUOX1‐2. UNIPROT codes: csNOX5 K9WT99-1; hNOX5 Q96PH1-4; hNOX1 Q9Y5S8-1; hNOX2 P04839; hNOX3 Q9HBY0-1; hNOX4 Q9NPH5-1; hDUOX1 Q9NRD9-1; hDUOX2 Q9NRD8-1. The sequences were aligned by Clustal Omega Multiple Sequence Alignment from EMBL.
Activities of the EF‐binding region mutants of csNOX5. Data are the average of duplicates
| csNOX5 construct | ΔAbs550 nm·s‐1 | |
|---|---|---|
| No CaCl2 | 1 mM CaCl2 | |
| Wild‐type | 0.0032 ± 0.0014 | 0.0159 ± 0.0004 |
| D611H | 0.0018 ± 0.0001 | 0.0036 ± 0.0008 |
| D631A | 0.0018 ± 0.0003 | 0.0019 ± 0.0006 |
| D631R | 0.0027 ± 0.0010 | 0.0016 ± 0.0003 |
| csNOX5 EF‐truncated | 0.0018 ± 0.0001 | 0.0025 ± 0.0003 |
| csNOX5 N‐lobe truncated | 0.0020 ± 0.0004 | 0.0035 ± 0.0003 |
| Background | 0.0005–0.001 | 0.0005–0.001 |
csNOX5 EF‐truncated comprises residues 209‐693 of csNOX5 and corresponds to a natural appearing variant of hNOX5, called NOX5ε, which lacks the EF‐domain
Background is measured in membranes not expressing csNOX5.
The role of calmodulin in NOX5 activation. The measurements were carried out in the presence of 1 mM CaCl2.
| csNOX5 protein | ΔAbs550 nm·s ‐1 |
|---|---|
| Wild‐type | 0.017 |
| Wild‐type + calmodulin | 0.016 |
| D631A + calmodulin | 0.002 |
| D631R + calmodulin | 0.002 |
| D611H + calmodulin | 0.002 |
Figure 10A physiologically unlikely binding mode of calmodulin to DH. (A) The predicted calmodulin‐binding region of hNOX5 is conserved in csNOX5. Bulky residues on positions 1, 5, 8, and 16 of the expected calmodulin‐binding loop correspond to Trp674, Phe678, Val681, and Val691 in hNOX5 and Trp647, Phe651, Val654, Val663 in csNOX5. Clustal Omega Multiple Sequence Alignment from EMBL was used for alignment (B) Crystal structure human calmodulin (golden) with four calcium ions (dark blue) bound to the putative calmodulin‐binding region of the DH‐domain of hNOX5 (residues 674‐685; light blue). Each lobe of the calmodulin is bound to one peptide through interactions with Trp674, Phe678, Val681, and Val691 of the DH peptide. Model images were displayed by UCSF Chimera. Structure deposited at PDB with code 6SZ5. (C) These residues on the putative calmodulin‐binding helix are, however, buried in the DH‐domain hydrophobic core as it can be seen in the crystal structure of csNOX5 DH‐domain (csNOX5: Trp647, Phe651, Val654, Val662).
Data collection and phasing statisticsa.
| Space group | P 21 21 21 |
| 0.185 (0.98) |
| 21.9 |
|
Cell dimensions
| 24.76, 60.84, 102.44 |
| 6.5 (1.1) | Free | 29.4 |
| Wavelength (Å) | 1.07227 | CC1/2 | 0.99 (0.53) | Root‐mean‐square bonds (Å) | 0.010 |
| Resolution (Å) | 2.2 | Completeness (%) | 99.7 (100) | Root‐mean‐square bonds (°) | 1.4 |
| Number of reflections | 8064 | Redundancy | 6.0 (6.3) |
Values in parentheses are for highest‐resolution shell.